Catalyst

Slingshot members are tracking this event:

PDUFA goal date set for November 28, 2018 for Catalyst Pharma's (CPRX) Firdapse in Lambert-Eaton Myasthenic Syndrome (LEMS)

Source Link:
http://ir.catalystpharma.com/news-releases/news-release-details/catalyst-pharmaceuticals-announces-second-quarter-2018-financial

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CPRX Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Nov 29, 2018
Occurred Source:
https://ir.catalystpharma.com/news-releases/news-release-details/fda-approves-firdapser-amifampridine-treatment-lambert-eaton
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Firdapse, Lambert-eaton Myasthenic Syndrome
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.